`
`Filed on behalf of:
`Ranbaxy Inc.
`Joseph M. Reisman
`Carol Pitzel Cruz
`Kerry S. Taylor
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`2040 Main Street, 14th Floor
`Irvine, CA 92614
`Tel.: (949) 760-0404
`Fax: (949) 760-9502
`E-mail: BoxRanbaxy332@knobbe.com
`
`
`
`
`
`
`
`
`
`
`
`Filed: April 26, 2016
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________________________
`
`RANBAXY INC.,
`Petitioner
`
`v.
`
`JAZZ PHARMACEUTICALS, INC.,
`Patent Owner
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case No. IPR2016-00024
`Patent 8,772,306
`
`
`
`
`
`
`
`
`
`
`PETITIONER’S OBJECTIONS TO ADMISSIBILITY OF EVIDENCE
`FILED WITH PATENT OWNER’S PRELIMINARY RESPONSE
`
`
`
`
`
`
`
`
`
`Ranbaxy v. Jazz
`Case IPR2016-00024
`U.S. Pat. 8,772,306
`
`
`
`Pursuant to 37 C.F.R. § 42.64(b), Petitioner objects as follows to the
`
`admissibility of evidence filed with Patent Owner’s Preliminary Response on
`
`January 15, 2016.
`
`Petitioner reserves its right: (1) to timely file a motion to exclude these
`
`objectionable exhibits, or portions thereof; (2) to challenge the credibility and/or
`
`weight that should be afforded to these exhibits, whether or not Petitioner files a
`
`motion to exclude the exhibits; (3) to challenge the sufficiency of the evidence to
`
`meet Patent Owner’s burden of proof on any issue, whether or not Patent Owner
`
`has objected to, or files a motion to exclude, the evidence; and (4) to cross examine
`
`any Patent Owner declarant within the scope of his or her direct testimony relating
`
`to these exhibits, without regard to whether Petitioner has objected to the testimony
`
`or related exhibits, and without regard to whether the testimony or related exhibits
`
`are ultimately found to be inadmissible.
`
`Evidence
`
`Objections
`
`Ex. 2001
`
`Relevance and Unfair Prejudice (FRE 402, 403):
`
`There exists no evidence to establish that this Exhibit qualifies as a
`
`printed publication that qualifies as prior art. Thus, this Exhibit is
`
`not relevant to the extent that it is not a printed publication.
`
`This Exhibit is also not relevant to the extent that it does not
`
`- 1 -
`
`
`
`Ranbaxy v. Jazz
`Case IPR2016-00024
`U.S. Pat. 8,772,306
`
`
`Evidence
`
`Objections
`
`support the proposition that it is cited for.
`
`Hearsay (FRE 802): This Exhibit is hearsay to the extent that it is
`
`as an out of court statement and is being used to prove the truth of
`
`the matter asserted.
`
`Ex. 2002
`
`Relevance and Unfair Prejudice (FRE 402, 403):
`
`This Exhibit is not relevant to the extent that it does not support
`
`the proposition that it is cited for.
`
`Hearsay (FRE 802): This Exhibit is hearsay to the extent that it is
`
`as an out of court statement and is being used to prove the truth of
`
`the matter asserted.
`
`Ex. 2003
`
`Relevance and Unfair Prejudice (FRE 402, 403):
`
`There exists no evidence to establish that this Exhibit is prior art to
`
`the ’306 patent. Thus, it is not relevant.
`
`Hearsay (FRE 802): This Exhibit is hearsay to the extent that it is
`
`as an out of court statement and is being used to prove the truth of
`
`the matter asserted.
`
`Ex. 2004
`
`Hearsay (FRE 802): This Exhibit is hearsay to the extent that it is
`
`as an out of court statement and is being used to prove the truth of
`
`- 2 -
`
`
`
`Ranbaxy v. Jazz
`Case IPR2016-00024
`U.S. Pat. 8,772,306
`
`
`Evidence
`
`Objections
`
`the matter asserted.
`
`Ex. 2005
`
`Relevance and Unfair Prejudice (FRE 402, 403):
`
`There exists no evidence to establish that this Exhibit is prior art to
`
`the ’306 patent. Thus, it is not relevant.
`
`Ex. 2006
`
`Hearsay (FRE 802): This Exhibit is hearsay to the extent that it is
`
`as an out of court statement and is being used to prove the truth of
`
`the matter asserted.
`
`Ex. 2007
`
`Hearsay (FRE 802): This Exhibit is hearsay to the extent that it is
`
`as an out of court statement and is being used to prove the truth of
`
`the matter asserted.
`
`Ex. 2008
`
`Relevance and Unfair Prejudice (FRE 402, 403):
`
`There exists no evidence to establish that this Exhibit is prior art to
`
`the ’306 patent. Thus, it is not relevant. Also, Par’s Petition for
`
`Inter Partes Review is not relevant to the current proceeding.
`
`Hearsay (FRE 802): This Exhibit is hearsay to the extent that it is
`
`as an out of court statement and is being used to prove the truth of
`
`the matter asserted.
`
`Ex. 2009
`
`Relevance and Unfair Prejudice (FRE 402, 403): Relevance and
`
`- 3 -
`
`
`
`Ranbaxy v. Jazz
`Case IPR2016-00024
`U.S. Pat. 8,772,306
`
`
`Evidence
`
`Objections
`
`Unfair Prejudice (FRE 402, 403):
`
`This Exhibit appears to not be prior art to the ’306 patent. Thus, it
`
`is not relevant. Also, Dr. Winkelman’s Declaration, filed with
`
`Par’s Petition for Inter Partes Review, is not relevant to the current
`
`proceeding.
`
`Hearsay (FRE 802): This Exhibit is hearsay to the extent that it is
`
`as an out of court statement and is being used to prove the truth of
`
`the matter asserted.
`
`Ex. 2017
`
`Relevance and Unfair Prejudice (FRE 402, 403):
`
`There exists no evidence to establish that this Exhibit is prior art to
`
`the ’306 patent. Thus, it is not relevant.
`
`
`
`
`
`Dated: April 26, 2016
`
`
`
`Respectfully submitted,
`
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`
`
`
`By: /Kerry Taylor/
`Joseph M. Reisman (Reg. No. 43,878)
`Carol Pitzel Cruz (Reg. No. 61,224)
`Kerry S. Taylor (Reg. No. 43,947)
`Customer No. 20,995
`
`Attorneys for Petitioner
`RANBAXY INC.
`(949) 760-0404
`
`- 4 -
`
`
`
`Ranbaxy v. Jazz
`Case IPR2016-00024
`U.S. Pat. 8,772,306
`
`
`CERTIFICATE OF SERVICE
`
`
`
`I hereby certify
`
`that a
`
`true and correct copy of
`
`the foregoing
`
`PETITIONER’S OBJECTIONS TO ADMISSIBILITY OF EVIDENCE
`
`SERVED WITH PATENT OWNER’S PRELIMINARY RESPONSE is being
`
`served on April 26, 2016, via email pursuant to 37 C.F.R. § 42.6(3) and agreement
`
`of the parties to lead and back up counsel for Jazz Pharmaceuticals, Inc. at the
`
`addresses below:
`
`F. Dominic Cerrito
`Evangeline Shih
`Frank C. Calvosa
`Quinn Emanuel Urquhart & Sullivan, LLP
`51 Madison Avenue 22nd Floor
`New York, NY 10010
`Telephone: (212) 849-7000
`Email: nickcerrito@quinnemanuel.com
`
` evangelineshih@quinnemanuel.com
`
` frankcalvosa@quinnemanuel.com
`
`John V. Biernacki
`Jones Day
`North Point, 901 Lakeside Avenue
`Cleveland, OH 44114
`Telephone: (216) 586-3939
`Email: jvbiernacki@jonesday.com
`
`
`Dated: April 26, 2016
`
`23160679
`
`
`
` /Kerry Taylor/
`Kerry S. Taylor (Reg. No. 43,947)
`Attorney for Petitioner
`RANBAXY INC.
`
`
`
`- 5 -